
|Videos|December 15, 2016
What Is Exciting in CLL Treatment Options?
Mary Golf, PharmD, discusses the latest in research options for CLL management.
Advertisement
In this clip, Mary Golf, PharmD, of Northwestern Memorial Hospital, discusses the latest in research options for chronic lymphocytic leukemia, or CLL, management. She notes that with targeted markers, "the side effects are more focused and managable."
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
3
Updates in Treatment of Unresectable Hepatocellular Carcinoma
4
Potential Benefits of GLP-1 Agonists in Reducing Chemotherapy-Related Toxicities in Breast Cancer
5









































































































































































































